NASDAQ Biotechnology Total Retu XNBI Indice
4674.34 USD
{{ price }}
0.899597%
{{change_pct}}%
PAYS
États-Unis
Marché
Nasdaq GIDS
Plus Haut - Plus Bas [24H]
4637.62
-
4702.16 USD
Nombre de composants
190
NASDAQ Biotechnology Total Retu Graphique des prix
Top 5 Gagnants au Cours des Dernières 24 Heures
| IRWD | Ironwood Pharmaceuticals | +36.34% | |
|---|---|---|---|
| NKTR | Nektar Therapeutics | +29.12% | |
| INSM | Insmed Incorporated | +28.65% | |
| MGNX | MacroGenics | +8.54% | |
| CGEN | Compugen | +5.29% |
Top 5 Perdants au Cours des Dernières 24 Heures
| UTHR | United Therapeutics | -14.32% | |
|---|---|---|---|
| MNKD | MannKind | -10.3% | |
| EGRX | Eagle Pharmaceuticals | -6.67% | |
| LXRX | Lexicon Pharmaceuticals | -5.91% | |
| CHRS | Coherus BioSciences | -5.76% |
NASDAQ Biotechnology Total Retu XNBI APERÇU FINANCIER ET COMMERCIAL
| NASDAQ Biotechnology Total Retu Prix de l'Indice | 4674.34 USD |
| Dernière clôture | 4472.96 USD |
| Ouverture | 4476.26 USD |
| Offre | 0 USD x 0 |
| Demande | 0 USD x 0 |
| Variation du jour | 4464.53 - 4532.84 USD |
| Plage sur 52 semaines | 4464.53 - 4532.84 USD |
| Volume | 0 USD |
| Volume moyen | N/A |
Informations de trading
NASDAQ Biotechnology Total Retu Historique des prix de l'Indice
| Plus haut sur 52 semaines | 4532.84 USD |
| Plus bas sur 52 semaines | 4464.53 USD |
| Moyenne mobile sur 50 jours | N/A |
| Moyenne mobile sur 200 jours | N/A |
XNBI Statistiques de l'indice
| Volume moyen (3 mois) | N/A |
| Volume journalier moyen (10 jours) | N/A |
Questions et réponses concernant l'indice NASDAQ Biotechnology Total Retu
Quel est le cours actuel de l'Indice XNBI ?
Le prix de l'Indice NASDAQ Biotechnology Total Retu XNBI aujourd'hui est de 4674.34 USD.
Comment acheter l'Indice NASDAQ Biotechnology Total Retu ?
Vous pouvez acheter l'indice XNBI sur la plateforme Nasdaq GIDS. Contactez votre conseiller financier pour choisir un courtier.
Quel est le symbole boursier de l'Indice NASDAQ Biotechnology Total Retu ?
Le symbole boursier ou ticker de l'Indice NASDAQ Biotechnology Total Retu est XNBI.
Combien de composants contient l'Indice NASDAQ Biotechnology Total Retu ?
L'Indice NASDAQ Biotechnology Total Retu contient 190 composants.
À quel pays appartient l'Indice NASDAQ Biotechnology Total Retu ?
L'Indice NASDAQ Biotechnology Total Retu fait référence à United States.
À quelle bourse appartient l'Indice NASDAQ Biotechnology Total Retu ?
L'Indice NASDAQ Biotechnology Total Retu fait référence à la bourse Nasdaq GIDS.
NASDAQ Biotechnology Total Retu COMPOSANTS
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA |
|---|
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA |
|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
| Amgen AMGN | $293.43 — |
+1.19
|
$157.78B — | $2.44M — | $289.79 — | $295.62 — | $157.78B — | 26.45 | $11.09 — |
| Gilead Sciences GILD | $110.09 — |
-2.58
|
$136.94B — | $8.83M — | $109.76 — | $112.24 — | $136.94B — | 23.77 | $4.63 — |
| Vertex Pharmaceuticals Incorporated VRTX | $451.52 — |
+1.2
|
$115.95B — | $1.29M — | $441.92 — | $455.64 — | $115.95B — | 0 | -$3.88 — |
| Regeneron Pharmaceuticals REGN | $523.53 — |
+1.15
|
$55.88B — | $1.17M — | $518.16 — | $529.99 — | $55.88B — | 13.15 | $39.79 — |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — |
| Alnylam Pharmaceuticals ALNY | $302.46 — |
-0.51
|
$39.64B — | $505.11K — | $301.34 — | $308.89 — | $39.64B — | 0 | -$2.09 — |
| Biogen BIIB | $135.49 — |
+1
|
$19.85B — | $989.56K — | $133.42 — | $136.84 — | $19.85B — | 13.25 | $10.22 — |
| Insmed Incorporated INSM | $90.93 — |
+28.65
|
$16.56B — | $15.43M — | $86 — | $91.86 — | $16.56B — | 0 | -$7.63 — |
| United Therapeutics UTHR | $281.36 — |
-14.32
|
$14.81B — | $2.8M — | $274.01 — | $291.24 — | $14.81B — | 13.08 | $21.5 — |
| Illumina ILMN | $87.98 — |
+3.53
|
$13.93B — | $2.95M — | $85 — | $89.74 — | $13.93B — | 0 | -$6.29 — |
| Incyte INCY | $70.07 — |
+0.26
|
$13.56B — | $1.92M — | $69.65 — | $70.96 — | $13.56B — | 350.35 | $0.2 — |
| Neurocrine Biosciences NBIX | $124.77 — |
-0.76
|
$12.44B — | $700.86K — | $124.39 — | $127.51 — | $12.44B — | 42.58 | $2.93 — |
| Exelixis EXEL | $42.52 — |
-0.93
|
$11.7B — | $1.78M — | $42.35 — | $43.5 — | $11.7B — | 19.59 | $2.17 — |
| BioMarin Pharmaceutical BMRN | $57.48 — |
+1.05
|
$11.02B — | $1.7M — | $56.53 — | $58.17 — | $11.02B — | 21.05 | $2.73 — |
| Qiagen QGEN | $46.22 — |
+0.11
|
$10.01B — | $1.81M — | $46.07 — | $46.72 — | $10.01B — | 107.48 | $0.43 — |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — |
| Blueprint Medicines BPMC | $127.97 — |
0
|
$8.28B — | $4.44M — | $127.75 — | $128.1 — | $8.28B — | 0 | -$2.51 — |
| Bio-Techne TECH | $51.4 — |
+3.05
|
$8.06B — | $3.33M — | $49.95 — | $51.68 — | $8.06B — | 60.47 | $0.85 — |
| Repligen RGEN | $132.87 — |
+0.9
|
$7.47B — | $618.5K — | $130.46 — | $134.31 — | $7.47B — | 0 | -$0.43 — |
| Grifols, S.A. GRFS | $9.02 — |
+2.15
|
$7.37B — | $463.34K — | $8.86 — | $9.07 — | $7.37B — | 33.40 | $0.27 — |
- {{ link.label }} {{link}}